Statement Of Cash Flows [Abstract]

Biotage - Filing #702086

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Interest paid, classified as operating activities	—	3,000,000 SEK	—	3,000,000 SEK	—
Interest received, classified as operating activities	—	0 SEK	—	0 SEK	—
Cash flows from (used in) operating activities	—	353,000,000 SEK	—	279,000,000 SEK	—
Cash flows from (used in) investing activities [abstract]
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities	—	2 8 2 SEK	—	- SEK	—
Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities	—	2,000,000 SEK	—	1,000,000 SEK	—
Purchase of property, plant and equipment, classified as investing activities	—	2 3 SEK	—	1 8 SEK	—
Purchase of intangible assets, classified as investing activities	—	3 3 SEK	—	43,000,000 SEK	—
Proceeds from sales of other long-term assets, classified as investing activities	—	- SEK	—	0 SEK	—
Cash flows from (used in) investing activities	—	3 41 SEK	—	62,000,000 SEK	—
Cash flows from (used in) financing activities [abstract]
Proceeds from borrowings, classified as financing activities	—	150,000,000 SEK	—	- SEK	—
Cash flows from (used in) financing activities	—	82,000,000 SEK	—	2 3 SEK	—
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	—	69,000,000 SEK	—	195,000,000 SEK	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	—	9,000,000 SEK	—	1 0 SEK	—
Cash and cash equivalents	311,000,000 SEK	—	37 1 SEK	—	186,000,000 SEK